review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Jean S Marshall | Q60329463 |
P2093 | author name string | Ian D Haidl | |
Jean-François Légaré | |||
Stephanie A Legere | |||
P2860 | cites work | Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts | Q24561756 |
The role of IL-33 and mast cells in allergy and inflammation | Q26783420 | ||
Mast cells as effectors in atherosclerosis | Q26995160 | ||
The role of mast cells in allergic inflammation | Q27003571 | ||
The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome | Q28288581 | ||
Chymase mediates injury and mitochondrial damage in cardiomyocytes during acute ischemia/reperfusion in the dog | Q28537860 | ||
Angiotensin II generation by mast cell alpha- and beta-chymases | Q28610117 | ||
Morphometrical and stereological analysis of myocardial mast cells in myocarditis and dilated cardiomyopathy. | Q33180037 | ||
Tryptase activates TGFbeta in human airway smooth muscle cells via direct proteolysis. | Q46688270 | ||
Chymase induces profibrotic response via transforming growth factor-beta 1/Smad activation in rat cardiac fibroblasts | Q46867288 | ||
Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. | Q47324915 | ||
Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium | Q47969185 | ||
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors | Q48425484 | ||
The controversial role of mast cells in fibrosis | Q50068930 | ||
Mast cells as sources of cytokines, chemokines, and growth factors. | Q50068970 | ||
Non-IgE mediated mast cell activation. | Q50069011 | ||
Changing the threshold-Signals and mechanisms of mast cell priming | Q50069023 | ||
Mast cell degranulation promotes ischemia-reperfusion injury in rat liver | Q50228623 | ||
Correlation between mast cell density and myocardial fibrosis in congestive heart failure patients. | Q50675712 | ||
The human cardiac mast cell: localization, isolation, phenotype, and functional characterization | Q50767564 | ||
Quantitative changes in mast cell populations after left ventricular assist device implantation. | Q51428172 | ||
Evidence for tissue angiotensin-converting enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique. | Q53573892 | ||
VEGF-A promotes cardiac stem cell engraftment and myocardial repair in the infarcted heart. | Q53617599 | ||
Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF. | Q54338960 | ||
IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways. | Q54368873 | ||
The novel role of mast cells in the microenvironment of acute myocardial infarction. | Q54389254 | ||
Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus. | Q54535403 | ||
Comparison between the collagen intensity and mast cell density in the lingual muscles and myocardium of autopsied chronic chagasic and nonchagasic patients | Q58843476 | ||
Inhibition of mast cell PGD2release protects against mannitol-induced airway narrowing | Q60168438 | ||
Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine | Q67535901 | ||
Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2 | Q73382005 | ||
Differential regulation of mast cell function by IL-10 and stem cell factor | Q73900176 | ||
Production of fibrogenic cytokines by cord blood-derived cultured human mast cells | Q73972452 | ||
Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production | Q74452712 | ||
Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state | Q79923829 | ||
CD117-positive cells of the heart: progenitor cells or mast cells? | Q33742772 | ||
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents | Q33755314 | ||
ADAM10 is required for SCF-induced mast cell migration | Q34026123 | ||
CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans | Q34106221 | ||
Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. | Q34329991 | ||
Progressive replacement of embryo-derived cardiac macrophages with age | Q34375144 | ||
Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells | Q34442444 | ||
Myocardial remodeling in diabetic cardiomyopathy associated with cardiac mast cell activation | Q34654120 | ||
Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine | Q35002029 | ||
Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart | Q35103548 | ||
Mast cell secretory granules: armed for battle | Q35182662 | ||
Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors | Q35183803 | ||
Cross-talk between human mast cells and bronchial epithelial cells in plasminogen activator inhibitor-1 production via transforming growth factor-β1. | Q35207676 | ||
Involvement of chymase-mediated angiotensin II generation in blood pressure regulation | Q35233098 | ||
Corin-deficient W-sh mice poorly tolerate increased cardiac afterload | Q35381245 | ||
The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions | Q35552846 | ||
Evidence for an active inflammatory process in the hibernating human myocardium | Q35788998 | ||
The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling Pathway | Q35841956 | ||
Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome | Q35850819 | ||
Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol | Q35887104 | ||
Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. | Q35900980 | ||
Stem cell factor programs the mast cell activation phenotype | Q35981165 | ||
Cromoglycate, not ketotifen, ameliorated the injured effect of warm ischemia/reperfusion in rat liver: role of mast cell degranulation, oxidative stress, proinflammatory cytokine, and inducible nitric oxide synthase | Q36079408 | ||
Prevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats | Q36144638 | ||
Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB | Q36174897 | ||
Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart | Q36225609 | ||
Signal transduction and chemotaxis in mast cells | Q36240848 | ||
IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity | Q36382107 | ||
The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation | Q36394723 | ||
Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts | Q36509613 | ||
Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models | Q36534366 | ||
Mast cell progenitor trafficking and maturation | Q36560191 | ||
New models for analyzing mast cell functions in vivo | Q36610811 | ||
A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters | Q44370359 | ||
Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure | Q44438460 | ||
Norepinephrine-induced cardiac hypertrophy and fibrosis are not due to mast cell degranulation | Q44631192 | ||
Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation. | Q44853398 | ||
A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canine grafted veins | Q44859380 | ||
Protective role of mast cells in homocysteine-induced cardiac remodeling | Q45182725 | ||
Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. | Q46034399 | ||
Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function. | Q46192933 | ||
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells | Q80736011 | ||
Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling | Q84916626 | ||
Eotaxin/CCL11 Levels Correlate With Myocardial Fibrosis and Mast Cell Density in Native and Transplanted Rat Hearts | Q85014745 | ||
Myocardial inflammatory infiltrate in human chronic chagasic cardiomyopathy: Immunohistochemical findings | Q87072610 | ||
Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase/mast cell protease 4-dependent mechanism | Q87147961 | ||
Correction for Lavine et al., Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart | Q87397419 | ||
Distribution of mast cells within the mouse heart and its dependency on Mitf | Q93341378 | ||
Chronic chymase inhibition preserves cardiac function after left ventricular repair in rats | Q94608691 | ||
Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. | Q36632214 | ||
Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33. | Q36744984 | ||
Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. | Q36837256 | ||
Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction | Q37047339 | ||
Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats | Q37079737 | ||
Lives of a heart cell: tracing the origins of cardiac progenitors | Q37132482 | ||
Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure | Q37133226 | ||
The pathogenesis of cardiac fibrosis. | Q37161329 | ||
IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1 | Q37246528 | ||
Cardiogenic differentiation and transdifferentiation of progenitor cells | Q37319214 | ||
IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. | Q37415365 | ||
Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions | Q37674001 | ||
Vascular endothelial growth factor promotes fibrosis resolution and repair in mice | Q37726957 | ||
TNFα in myocardial ischemia/reperfusion, remodeling and heart failure | Q37767172 | ||
Are mast cells instrumental for fibrotic diseases? | Q38183377 | ||
Hematopoietic Kit Deficiency, rather than Lack of Mast Cells, Protects Mice from Obesity and Insulin Resistance | Q38299158 | ||
IL-33 and Thymic Stromal Lymphopoietin in mast cell functions | Q38519638 | ||
Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational concepts | Q38566665 | ||
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. | Q38875774 | ||
Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle | Q38885347 | ||
Persistent change in cardiac fibroblast physiology after transient ACE inhibition | Q38963920 | ||
Redefinition of the human mast cell transcriptome by deep-CAGE sequencing | Q38967503 | ||
5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice | Q38990137 | ||
A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. | Q39637223 | ||
Short-term ACE inhibition confers long-term protection against target organ damage | Q39654678 | ||
Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus | Q39887208 | ||
Mast cells promote proliferation and migration and inhibit differentiation of mesenchymal stem cells through PDGF. | Q39903739 | ||
Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells | Q40153856 | ||
Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. | Q40216222 | ||
Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis | Q40740841 | ||
The differentiation and function of myofibroblasts is regulated by mast cell mediators | Q40768319 | ||
Cord blood-derived human cultured mast cells produce transforming growth factor beta1. | Q40969668 | ||
Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. | Q41125883 | ||
Nonclassical resident macrophages are important determinants in the development of myocardial fibrosis | Q41186913 | ||
TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis | Q41324289 | ||
Formalin sensitivity and differential staining of mast cells in human dermis | Q42091758 | ||
Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction. | Q42278450 | ||
Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts | Q42946844 | ||
Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase | Q43626582 | ||
Mast cells in acute and chronic rejection of rat cardiac allografts--a major source of basic fibroblast growth factor | Q43675872 | ||
Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells | Q43720282 | ||
Mast cells and macrophages in normal C57/BL/6 mice | Q44067220 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
inflammation | Q101991 | ||
mast cell | Q191989 | ||
neovascularization | Q1281049 | ||
myocardial ischemia | Q6947906 | ||
P304 | page(s) | 580 | |
P577 | publication date | 2019-03-28 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention | |
P478 | volume | 10 |
Search more.